1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX
59.05 0.91 (1.57%)
788.9K
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Protagonist Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details

Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 11 analysts

Protagonist Therapeutics Inc has a share price target of US$ 70, revenue growth forecast of -84.6%, and profit growth estimate of -146.1% for FY25, based on top 11 analyst calls.